Digital Ischemia for the Rheumatologist

Sunday, April 14, 2024

9:55 AM – 10:30 AM Central Time

Moderator(s)

NA

Narender Annapureddy, MD, MS

Vanderbilt University Medical Center
Nashville, TN, United States

Disclosure(s): AURINIA: Advisor or Review Panel Member (Terminated, August 10, 2023); GlaxoSmithKlein(GSK): Consultant (Ongoing); Novartis: Advisor or Review Panel Member (Terminated, July 29, 2022)

Speaker(s)

TF

Tracy Frech, MD, MS

Vanderbilt University Medical Center
Nashville, TN, United States

Disclosure(s): No financial relationships with ineligible companies to disclose

In this session, the prevention of digital ischemia through Raynaud's phenomenon assessment will be discussed. The key diagnostic components of the physical exam, laboratory testing, and imaging assessment will be reviewed. The rationale for state-of-the art treatment considerations for vascular-based therapeutics will be defined.

Learning Objectives:

Discuss a preventative approach for digital ischemia related to Raynaud’s Phenomenon.
Describe key diagnostic rheumatologic considerations in acute digital ischemia.
Define treatment options for rheumatic digital ischemia.

Presentations:

9:55 AM – 10:20 AM Central Time

Digital Ischemia for the Rheumatologist
Speaker: Tracy Frech, MD, MS – Vanderbilt University Medical Center
10:20 AM – 10:30 AM Central Time

Q&A
Q&A Moderator: Narender Annapureddy, MD, MS – Vanderbilt University Medical Center
Q&A Presenter: Tracy Frech, MD, MS – Vanderbilt University Medical Center